These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 17595758)
1. Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel. Wada M; Jinno H; Ueda M; Ikeda T; Kitajima M; Konno T; Watanabe J; Ishihara K Anticancer Res; 2007; 27(3B):1431-5. PubMed ID: 17595758 [TBL] [Abstract][Full Text] [Related]
2. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. Konno T; Watanabe J; Ishihara K J Biomed Mater Res A; 2003 May; 65(2):209-14. PubMed ID: 12734814 [TBL] [Abstract][Full Text] [Related]
3. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles. Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model. Tamura K; Kikuchi E; Konno T; Ishihara K; Matsumoto K; Miyajima A; Oya M BMC Cancer; 2015 Apr; 15():317. PubMed ID: 25928041 [TBL] [Abstract][Full Text] [Related]
5. Translymphatic chemotherapy targeting sentinel lymph nodes using a novel phospholipid polymer-Paclitaxel conjugate. Oyama T; Takeuchi H; Matsuda S; Ozawa S; Kitajima M; Kitagawa Y Anticancer Res; 2014 Apr; 34(4):1751-7. PubMed ID: 24692706 [TBL] [Abstract][Full Text] [Related]
6. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303 [TBL] [Abstract][Full Text] [Related]
8. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel. Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal administration of paclitaxel solubilized with poly(2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) for peritoneal dissemination of gastric cancer. Soma D; Kitayama J; Konno T; Ishihara K; Yamada J; Kamei T; Ishigami H; Kaisaki S; Nagawa H Cancer Sci; 2009 Oct; 100(10):1979-85. PubMed ID: 19604244 [TBL] [Abstract][Full Text] [Related]
10. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth. Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
12. Novel immunosuppressant agents targeting activated lymphocytes by biocompatible MPC polymer conjugated with interleukin-2. Chiba N; Ueda M; Shimada T; Jinno H; Watanabe J; Ishihara K; Kitajima M Eur Surg Res; 2007; 39(2):103-10. PubMed ID: 17299267 [TBL] [Abstract][Full Text] [Related]
13. Morphology and in vitro release kinetics of drug-loaded micelles based on well-defined PMPC-b-PBMA copolymer. Chu H; Liu N; Wang X; Jiao Z; Chen Z Int J Pharm; 2009 Apr; 371(1-2):190-6. PubMed ID: 19162151 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. Ho EA; Vassileva V; Allen C; Piquette-Miller M J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344 [TBL] [Abstract][Full Text] [Related]
15. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Liang H; Yang Q; Deng L; Lu J; Chen J Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948 [TBL] [Abstract][Full Text] [Related]
16. Thermosensitive poly(organophosphazene)-paclitaxel conjugate gels for antitumor applications. Chun C; Lee SM; Kim SY; Yang HK; Song SC Biomaterials; 2009 Apr; 30(12):2349-60. PubMed ID: 19178941 [TBL] [Abstract][Full Text] [Related]
17. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer. Liu J; Meisner D; Kwong E; Wu XY; Johnston MR Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391 [TBL] [Abstract][Full Text] [Related]
18. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. Ho EA; Soo PL; Allen C; Piquette-Miller M J Control Release; 2007 Jan; 117(1):20-7. PubMed ID: 17113177 [TBL] [Abstract][Full Text] [Related]
19. A TPGS-incorporating nanoemulsion of paclitaxel circumvents drug resistance in breast cancer. Bu H; He X; Zhang Z; Yin Q; Yu H; Li Y Int J Pharm; 2014 Aug; 471(1-2):206-13. PubMed ID: 24866272 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. Knight V; Koshkina NV; Golunski E; Roberts LE; Gilbert BE Trans Am Clin Climatol Assoc; 2004; 115():395-404; discussion 404. PubMed ID: 17060982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]